This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Orsobio, Inc.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: The Innovative Contributions of Eva Hambruch
Introduction
Eva Hambruch is a prominent inventor based in Mannheim, Germany. She has made significant contributions to the field of biochemistry, particularly in the development of compounds that interact with liver X receptors. With a total of 3 patents to her name, her work is paving the way for advancements in therapeutic applications.
Latest Patents
Among her latest patents, Eva has developed LXR modulators with bicyclic core moiety. These inventions relate to bicyclic compounds, such as indoles, that contain a sulfonyl moiety. They bind to the liver X receptor (LXRα and/or LXRβ) and act preferably as inverse agonists of LXR. This innovative approach has the potential to influence various metabolic processes and offers new avenues for treatment.
Career Highlights
Eva currently works at Orsobio, Inc., where she continues to push the boundaries of scientific research. Her expertise in the field has led to groundbreaking discoveries that are essential for understanding and manipulating biological pathways.
Collaborations
Throughout her career, Eva has collaborated with notable colleagues, including Christian Gege and Olaf Kinzel. These partnerships have fostered a dynamic research environment that encourages innovation and the sharing of ideas.
Conclusion
Eva Hambruch's contributions to the field of biochemistry exemplify the impact of innovative thinking in science. Her patents and ongoing research are vital for the future of therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile